SSY GROUP (02005): Pibedil has been approved by the National Medical Products Administration (NMPA) for registration as an active pharmaceutical ingredient for use in marketed formulations.
Shi Si Yao Group (02005) announced that their product Pibedil has been approved for registration by the China National Medical Products Administration.
SSY GROUP (02005) announced that the group's Pibedil has been approved by the China National Medical Products Administration as a raw material for use in marketed formulations, making it the third domestic company to receive approval. Pibedil is mainly used for the treatment of Parkinson's disease and circulatory disorders.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
